Quality evidence is needed to support a new Medicare Part D medication therapy management (MTM) program performance measure, prompting a scoping review on MTM services and associated outcomes.
Catherine E. Cooke, PharmD, MS, BCPS
Advertisement
Articles by Catherine E. Cooke, PharmD, MS, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Expands Tirzepatide Label to Reduce Cardiovascular Risk in Type 2 Diabetes
2
DOJ Abandons Olmstead Defense as Texas v Kennedy Advances
3
Myasthenia Gravis Linked to Greater Longevity Than Multiple Sclerosis
4
Midsized Biotechs Strike MFN Drug Pricing Deals
5